OBJECTIVE: To investigate the value of non-invasive reperfusion indices in acute myocardial infarction, avoiding the possible need for acute coronary angiography and subsequent angioplasty. DESIGN: In a prospective angiographic study, seven potential ECG or clinical markers of reperfusion were analysed in 230 patients with acute myocardial infarction. In all patients two 12 lead ECGs were used: the ECG on admission and the ECG immediately before coronary angiography. Non-invasive markers of reperfusion determined just before coronary angiography were prospectively correlated to thrombolysis in myocardial infarction (TIMI) flow. Data analysis correlated these non-invasive indices with coronary flow (analysis A: TIMI 2-3 v TIMI 0-1 flow; analysis B: TIMI 3 v TIMI 0-2 flow). RESULTS: A sudden decrease in chest pain was the most common sign of reperfusion (36%), followed by reduction in ST segment elevation by >/= 50% (30%), and the development of a terminal negative T wave (20%) in the lead with the highest ST segment elevation. Reduction in ST segment elevation by > or = 50% and the appearance of an accelerated idioventricular rhythm (AIVR) had the highest positive predictive value for reperfusion. For analyses A and B, the positive predictive values were 85% and 66% for resolution of ST segment elevation, and 94% and 59% for AIVR, respectively. The presence of three or more non-invasive markers of reperfusion predicted TIMI 3 flow accurately in 80% of cases. CONCLUSIONS: The prospective use of non-invasive indices of reperfusion is simple, practical, and can be of value in assessing coronary patency in patients admitted with acute myocardial infarction. Using these indices, discrimination between TIMI 0-1 and TIMI 2-3 flow can be made with good accuracy. However, TIMI 3 flow cannot be determined reliably. The use of such non-invasive indices depends on the goal of reperfusion.
OBJECTIVE: To investigate the value of non-invasive reperfusion indices in acute myocardial infarction, avoiding the possible need for acute coronary angiography and subsequent angioplasty. DESIGN: In a prospective angiographic study, seven potential ECG or clinical markers of reperfusion were analysed in 230 patients with acute myocardial infarction. In all patients two 12 lead ECGs were used: the ECG on admission and the ECG immediately before coronary angiography. Non-invasive markers of reperfusion determined just before coronary angiography were prospectively correlated to thrombolysis in myocardial infarction (TIMI) flow. Data analysis correlated these non-invasive indices with coronary flow (analysis A: TIMI 2-3 v TIMI 0-1 flow; analysis B: TIMI 3 v TIMI 0-2 flow). RESULTS: A sudden decrease in chest pain was the most common sign of reperfusion (36%), followed by reduction in ST segment elevation by >/= 50% (30%), and the development of a terminal negative T wave (20%) in the lead with the highest ST segment elevation. Reduction in ST segment elevation by > or = 50% and the appearance of an accelerated idioventricular rhythm (AIVR) had the highest positive predictive value for reperfusion. For analyses A and B, the positive predictive values were 85% and 66% for resolution of ST segment elevation, and 94% and 59% for AIVR, respectively. The presence of three or more non-invasive markers of reperfusion predicted TIMI 3 flow accurately in 80% of cases. CONCLUSIONS: The prospective use of non-invasive indices of reperfusion is simple, practical, and can be of value in assessing coronary patency in patients admitted with acute myocardial infarction. Using these indices, discrimination between TIMI 0-1 and TIMI 2-3 flow can be made with good accuracy. However, TIMI 3 flow cannot be determined reliably. The use of such non-invasive indices depends on the goal of reperfusion.
Authors: P Klootwijk; A Langer; S Meij; C Green; R F Veldkamp; A M Ross; P W Armstrong; M L Simoons Journal: Eur Heart J Date: 1996-05 Impact factor: 29.983
Authors: P Clemmensen; E M Ohman; D C Sevilla; S Peck; N B Wagner; P S Quigley; P Grande; K L Lee; G S Wagner Journal: Am J Cardiol Date: 1990-12-15 Impact factor: 2.778
Authors: M W Krucoff; M A Croll; J E Pope; K S Pieper; P M Kanani; C B Granger; R F Veldkamp; B L Wagner; S T Sawchak; R M Califf Journal: Am J Cardiol Date: 1993-01-15 Impact factor: 2.778
Authors: S G Ellis; E R da Silva; G Heyndrickx; J D Talley; C Cernigliaro; G Steg; C Spaulding; M Nobuyoshi; R Erbel; C Vassanelli Journal: Circulation Date: 1994-11 Impact factor: 29.690
Authors: F Mauri; A P Maggioni; M G Franzosi; C de Vita; E Santoro; L Santoro; P Giannuzzi; G Tognoni Journal: J Am Coll Cardiol Date: 1994-09 Impact factor: 24.094
Authors: Kimmo Koivula; Kjell Nikus; Juho Viikilä; Jyrki Lilleberg; Heini Huhtala; Yochai Birnbaum; Markku Eskola Journal: Ann Noninvasive Electrocardiol Date: 2018-09-06 Impact factor: 1.468
Authors: Hendrik Bonnemeier; Jasmin Ortak; Uwe K H Wiegand; Frank Eberhardt; Frank Bode; Heribert Schunkert; Hugo A Katus; Gert Richardt Journal: Ann Noninvasive Electrocardiol Date: 2005-04 Impact factor: 1.468
Authors: Jung Sun Cho; Kye Hun Kim; Woo Seok Lee; Hyun Ju Yoon; Nam Sik Yoon; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Youngkeun Ahn; Myung Ho Jeong; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang Journal: Korean J Intern Med Date: 2010-08-31 Impact factor: 2.884